InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank87
3Y CAGR-0.1%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-0.1%/yr
Annual compound
Percentile
P87
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.40M-18.0%
2025$1.71M+55.0%
2024$1.10M-21.5%
2023$1.40M+158.1%
2022$543546.00-
2021$0.00+100.0%
2020$-183090.00-94.9%
2019$-93940.00-1.3%
2018$-92777.00-
2017$0.00-